The value of plasma markers for the clinical behaviour of phaeochromocytomas | Zendy

E. van der Harst | Zendy; WW de Herder | Zendy; Ronald R. de Krijger | Zendy; Hajo A. Bruining | Zendy; H. J. Bonjer | Zendy; SW Lamberts | Zendy; Anton H. van den Meiracker | Zendy; Theo Stijnen | Zendy; Frans Boomsma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The value of plasma markers for the clinical behaviour of phaeochromocytomas

Author(s) -

E. van der Harst,

WW de Herder,

Ronald R. de Krijger,

Hajo A. Bruining,

H. J. Bonjer,

SW Lamberts,

Anton H. van den Meiracker,

Theo Stijnen,

Frans Boomsma

Publication year - 2002

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje.0.1470085

Subject(s) - medicine , asymptomatic , pheochromocytoma , chromogranin a , endocrinology , basal (medicine) , catecholamine , epinephrine , metanephrines , hyperplasia , concomitant , immunohistochemistry , insulin

Phaeochromocytomas (PCCs) are widely known for their clinical unpredictability. This study intends to define predictive plasma markers for their variable postoperative behaviour. Furthermore, the diagnostic accuracy of these plasma tests was determined.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research